Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

Clinical trial NCT00929539 · COMPLETED

Trial details

NCT number: NCT00929539
Sponsor: Akros Pharma Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type II Diabetes Mellitus

Start date: 2009-06-01
Primary completion: 2010-05-01
Enrollment: 496

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.